Niagen Bioscience has been announced as the premiere sponsor of the inaugural “NAD for Health: Opportunities & Challenges” conference, hosted by the University of Copenhagen. The event aims to bring together researchers, industry experts, and healthcare professionals to discuss recent developments and future directions in NAD-related health science.
The conference will focus on the scientific, clinical, and commercial aspects of NAD (nicotinamide adenine dinucleotide) and its potential applications in health and disease management. Participants will explore both the opportunities and challenges associated with NAD research and its translation into therapies.
**Why this matters**
NAD plays a critical role in cellular metabolism and aging, making it a significant target for health research. By supporting this conference, Niagen Bioscience is facilitating collaboration and knowledge exchange that could accelerate advancements in NAD-based treatments and improve understanding of their impact on human health.
Source: NewsData